|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society, . Colorectal Cancer: Facts and Figures 2021. American Cancer Society; 2021
|
|
3
|
Lee H, Choi DW, Cho YB, Yun SH, Kim HC, Lee WY, Heo JS, Choi SH, Jung KU and Chun HK: Recurrence pattern depends on the location of colon cancer in the patients with synchronous colorectal liver metastasis. Ann Surg Oncol. 21:1641–1646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Longley DB, Harkin DP and Johnston PG: 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer. 3:330–338. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Kalantari HR, Haens GD, Paesmans M, Peeters M, Efira A and Humblet Y: A phase II randomized study of combined infusion al leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatinin patients with metastatic colorectal cancer. Acta Gastroenterol Belg. 75:14–21. 2012.PubMed/NCBI
|
|
6
|
Verhoeyen ME, Bovy A, Collins G, Muir S, Robinson S, de Vos CH and Colliver S: Increasing antioxidant levels in tomatoes through modification of the flavonoids biosynthetic pathway. J Exp Bot. 53:2099–2106. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mir IA and Tiku AB: Chemopreventive and therapeutic potential of ‘naringenin’, a flavanone present in citrus fruits. Nutr Cancer. 67:27–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Patel K, Singh GK and Patel DK: A review on pharmacological and analytical aspects of naringenin. Chin J Integr Med. 24:551–560. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bodduluru LN, Kasala ER, Madhana RM, Barua CC, Hussain MI, Haloi P and Borah P: Naringenin ameliorates inflammation and cell proliferation in benzo(a)pyrene induced pulmonary carcinogenesis by modulating CYP1A1, NFκB and PCNA expression. Int Immunopharmacol. 30:102–110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park HJ, Choi YJ, Lee JH and Nam HJ: Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells. Food Chem Toxicol. 99:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Silambarasan T and Raja B: Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Eur J Pharmacol. 679:81–89. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Terao J, Piskula M and Yao Q: Protective effect of epicatechin gallate, and guercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys. 308:278–284. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naso L, Martínez VR, Lezama L, Salado C, Valcarcel M, Ferrer EG and Williams PAM: Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin. Bioorg Med Chem. 24:4108–4119. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dung TD, Lin CH, Binh TV, Hsu HH, Su CC, Lin YM, Tsai CH, Tsai FJ, Kuo WW, Chen LM and Huang CY: Diosmin induces cell apoptosis through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells and blocks tumour growth in xenografted nude mice. Food Chem. 132:2065–2073. 2012. View Article : Google Scholar
|
|
15
|
Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Attardi LD and Jacks T: The role of p53 in tumor suppression: Lessons from mouse models. Cell Mol Life Sci. 55:48–63. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis. 21:485–495. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Terzic J, Grivennikov S, Karin E and Karin M: Inflammation and colon cancer. Gastroenterology. 138:2101–2114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lakatos PL and Lakatos L: Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World J Gastroenterol. 14:3937–3947. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Atreya I, Atreya R and Neurath MF: NF-kappaB in inflammatory bowel disease. J Intern Med. 263:591–596. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu H, Pardoll D and Jove R: STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer. 9:798–809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi X, Luo X, Chen T, Guo W, Liang C, Tang S and Mo J: Naringenin inhibits migration, invasion, induces apoptosis in human lung cancer cells and arrests tumour progression in vitro. J Cell Mol Med. 25:2563–2571. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dung TC, Lin CH, Binh TV, Hsu HH, Su CC, Lin YM, Tsai CH, Tsai FJ, Kuo WW, Chen LM and Huang CY: Diosmin induces cell apoptosis through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells and blocks tumour growth in xenografted nude mice. Food Chemistry. 132:2065–2073. 2012. View Article : Google Scholar
|
|
24
|
Khan N, Jajeh F, Eberhard EL, Miller DD, Albrecht DM, Van Doorn R, Hruby MD, Maresh ME, Clipson L, Mukhtar H and Halberg RB: Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer. Int J Cancer. 145:3022–3032. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu Z, Huang B, Liu J, Wu X, Luo N, Wang X, Zheng X and Pan X: Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes. Toxicology. 410:231–246. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Y, Yuan K, Tang M, Yue J, Bao L, Wu S, Zhang Y, Li Y, Wang Y, Ou X, et al: Melatonin inhibiting the survival of human gastric cancer cells under ER stress involving autophagy and Ras-Raf-MAPK signaling. J Cell Mol Med. 25:1480–1492. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morgan DM: Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol Biol. 79:179–183. 1998.PubMed/NCBI
|
|
28
|
Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chou TC: Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 58:621–681. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang N, Wu ZM, McGowan E, Shi J, Hong ZB, Ding CW, Xia P and Di W: Arsenic trioxide and cisplatin synergism increase cytotoxicity in human ovarian cancer cells: Therapeutic potential for ovarian cancer. Cancer Sci. 100:2459–2464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nafees S, Mehdi SH, Zafaryab M, Zeya B, Sarwar T and Rizvi MM: Synergistic interaction of Rutin and Silibilin on human colon cancer cell line. Arch Med Res. 49:226–234. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Irshad M, Mehdi SJ, Al-Fatlawi AA, Zafaryab M, Ali A and Ahmad I: Phytochemical Composition of Cassia fistula fruit extracts and its anticancer activity against human cancer cell lines. J Biol Act Prod Nat. 4:158–170. 2014.
|
|
33
|
Wu M, Lao Y, Xu N, Wang X, Tan H, Fu W, Lin Z and Xu H: Guttiferone K induces autophagy and sensitizes cancer cells to nutrient stress-induced cell death. Phytomedicine. 22:902–910. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu L, Fan J, Ai G, Liu J, Luo N, Li C and Cheng Z: Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol Res. 52:372019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Saraste A and Pulkki K: Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 45:528–537. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hollman PC and Katan MB: Dietary flavonoids: Intake, health effects and bioavailability. Food Chem Toxicol. 37:937–942. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ren W, Qiao Z, Wang H, Zhu L and Zhang L: Flavonoids: Promising anticancer agents. Med Res Rev. 23:519–534. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mishra J, Dromund J, Quazi SH, Karanki SS, Shaw JJ, Chen B and Kumar N: Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit Rev Oncol Hematol. 86:232–250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Key TJ: Fruit and vegetables and cancer risk. Br J Cancer. 104:6–11. 2004. View Article : Google Scholar
|
|
41
|
Park JH, Jin CY, Lee BK, Kim GY, Choi YH and Jeong YK: Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol. 46:3684–3690. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Totta P, Acconcia F, Leone S, Cardillo I and Marino M: Mechanisms of Naringenin-induced apoptotic cascade in cancer cells: Involvement of estrogen receptor ?? and ?? Signalling. IUBMB Life. 56:491–499. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lewinska A, Grochala JA, Kwasniewicz E, Deregowska A and Wnuk M: Diosmin induced senescence, apoptosis and autophagy in breast cancer cells of different p53 status and ERK activity. Toxicol Lett. 265:117–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lewinska A, Siwak J, Rzezutek I and Wnuk M: Diosmin induces genotoxicity and apoptosis in DU145 prostate cancer cell line. Toxicol In Vitro. 29:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lewin B, Cassimeris L and Lingappa VR: Cell, Jones & Bartlett Publishers; 2015
|
|
46
|
Stewart ZA, Westfall MD and Pietenpol JA: Cell cycle dysregulation and anticancer therapy. Trends Pharmacol Sci. 24:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mills CC, Kolb EA and Sampson VB: Development of chemotherapy with cell-cycle inhibitors for adult and pediatric cancer therapy. Cancer Res. 78:320–325. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Arul D and Subramanian P: Naringenin (Citrus Flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res. 19:763–770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Khan KH, Codesido MB and Molife LR: Cancer therapeutics: Targeting the apoptotic pathway. Crit Rev Oncol Hematol. 90:200–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kerr JF, Wyllie AH and Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Jurisicova A, Varmuza S and Casper RF: Programmed cell death and human embryo fragmentation. Mol Hum Reprod. 2:93–98. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ahamad MS, Siddiqui S, Jafri A, Ahmad S and Afzal M: Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One. 9:e1100032014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kagan VE, Fabisiak JP, Shvedova AA, Tyurina YY, Tyurin VA, Schor NF and Kawai K: Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett. 477:1–7. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kojima M, Morisaki T, Sasaki N, Nakano K, Mibu R, Tanaka M and Katano M: Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res. 24:675–681. 2004.PubMed/NCBI
|
|
56
|
Naugler WE and Karin M: NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev. 18:19–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
